Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXNQ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,156
Award facts
- Contract value 100% obligated
- $20,156.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded December 1, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $20,156.32 in firm fixed-price procurement for Biktarvy 50-200-25 mg tablets (30-count units), a pharmaceutical product used in HIV treatment. The award represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. The contract includes performance in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains this comprehensive global pharmaceutical support vehicle through which it supplies brand-name and generic medications, vaccines, and specialized medical supplies to military healthcare systems, the Defense Health Agency, and other federal health programs. As a child contract under the larger SPE2DX IDV, this delivery order exemplifies the company's critical role in supporting federal medical supply chains across multiple therapeutic domains. The award reflects DLA's reliance on established pharmaceutical prime vendors to rapidly fulfill urgent military healthcare medication requirements with stable, firm fixed pricing.
Quick answers
Who was awarded contract SPE2DR26FXNQ9?
SPE2DR26FXNQ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FXNQ9 worth?
The government has obligated $20,156 on SPE2DR26FXNQ9.
Is contract SPE2DR26FXNQ9 an order under another contract?
Yes. SPE2DR26FXNQ9 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXNQ9 competed?
The extent of competition for SPE2DR26FXNQ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award